SAR-260093 | m-entrepreneurship.com

Product Name :
SAR-260093

Search keywords :
MBX-2982

drugId :
null

Target Vo:
Glucose-dependent insulinotropic receptor

Target Vo Short Name :
GPR119

Moa_Name:
Glucose-dependent insulinotropic receptor agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Cymabay Therapeutics Inc

Active Company_Name :
AdventHealth Translational Research Institute

Active Indication_Name:
Diabetes Mellitus, Type 1

In Active Indication_Name:
Diabetes Mellitus

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD99 Rabbit mAb medchemexpress
Licaminlimab manufacturer
Phospho-Tau (Thr181) Antibody: Phospho-Tau (Thr181) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 79 kDa, targeting to Phospho-Tau (Thr181). It can be used for WB,IP assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts